Badreddin Edris - Sep 3, 2024 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Operating Officer
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol
SWTX
Transactions as of
Sep 3, 2024
Transactions value $
-$812,954
Form type
4
Date filed
9/4/2024, 04:05 PM
Previous filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale -$493K -12.3K -4.93% $40.11 237K Sep 3, 2024 Direct F1, F2
transaction SWTX Common Stock Sale -$190K -4.62K -1.95% $41.12 233K Sep 3, 2024 Direct F1, F3
transaction SWTX Common Stock Sale -$130K -3.08K -1.32% $42.08 230K Sep 3, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.61 to $40.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.77 to $41.725. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.